CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-26 | Kress Jean-Paul CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +83,296,638 | 83,296,638 | ||
| 2025-05-22 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Resnick Joshua Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Kalir Erez Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Lundberg Sven Ante Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Beckman Daniella Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Patterson Matthew R Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-22 | Namouni Fouad Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-05-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,361 | $0.56 | $1K | 911,318 |
| 2025-05-06 | Chakraborty Tirtha Chief Sci Off & Head Tech Ops | Shares withheld for taxes | −876 | $0.56 | $491 | 217,416 |
| 2025-05-01 | Choi Han Wook Chief Financial Officer | Shares withheld for taxes | −2,061 | $0.66 | $1K | 51,280 |
| 2025-05-01 | Chakraborty Tirtha Chief Sci Off & Head Tech Ops | Shares withheld for taxes | −985 | $0.66 | $650 | 219,254 |
| 2025-05-01 | Chakraborty Tirtha Chief Sci Off & Head Tech Ops | Shares withheld for taxes | −962 | $0.66 | $635 | 218,292 |
| 2025-05-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,751 | $0.66 | $2K | 916,201 |
| 2025-05-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,522 | $0.66 | $2K | 913,679 |
| 2025-02-13 | Attar Eyal C. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,227 | $1.42 | $3K | 126,625 |
| 2025-02-10 | Attar Eyal C. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,554 | $1.37 | $3K | 128,852 |
| 2025-02-06 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −1,033 | $1.50 | $2K | 220,239 |
| 2025-02-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,787 | $1.50 | $4K | 918,952 |
Page 7 of 18 · 344 trades